NOV Inc. (NYSE:NOV - Free Report) - Analysts at Zacks Research reduced their Q2 2025 earnings estimates for shares of NOV in a research report issued to clients and investors on Friday, May 23rd. Zacks Research analyst R. Department now expects that the oil and gas exploration company will post earnings per share of $0.29 for the quarter, down from their prior estimate of $0.30. The consensus estimate for NOV's current full-year earnings is $1.40 per share. Zacks Research also issued estimates for NOV's FY2025 earnings at $1.09 EPS.
NOV (NYSE:NOV - Get Free Report) last released its earnings results on Monday, April 28th. The oil and gas exploration company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). The firm had revenue of $2.10 billion for the quarter, compared to the consensus estimate of $2.11 billion. NOV had a return on equity of 9.88% and a net margin of 7.16%. NOV's revenue was down 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.30 EPS.
Several other equities research analysts have also recently issued reports on the stock. Royal Bank of Canada reduced their price objective on shares of NOV from $20.00 to $19.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 30th. Susquehanna dropped their price objective on shares of NOV from $21.00 to $19.00 and set a "positive" rating for the company in a research note on Monday, April 14th. Barclays reduced their target price on shares of NOV from $13.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, April 30th. Raymond James raised their target price on shares of NOV from $18.00 to $19.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Finally, Stifel Nicolaus dropped their price objective on shares of NOV from $25.00 to $23.00 and set a "buy" rating on the stock in a research note on Tuesday, April 15th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $17.50.
Get Our Latest Research Report on NOV
NOV Price Performance
Shares of NOV stock traded down $0.12 on Monday, hitting $12.19. 2,822,705 shares of the company traded hands, compared to its average volume of 3,960,486. The stock has a market capitalization of $4.58 billion, a P/E ratio of 7.57, a price-to-earnings-growth ratio of 1.02 and a beta of 1.27. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.64 and a current ratio of 2.46. NOV has a 52 week low of $10.84 and a 52 week high of $21.20. The business has a 50-day simple moving average of $12.78 and a 200 day simple moving average of $14.32.
NOV Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, June 27th. Shareholders of record on Friday, June 13th will be issued a $0.075 dividend. The ex-dividend date is Friday, June 13th. This represents a $0.30 dividend on an annualized basis and a dividend yield of 2.46%. NOV's dividend payout ratio is currently 20.00%.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the business. Focus Partners Wealth purchased a new position in shares of NOV during the first quarter worth $214,000. Bayforest Capital Ltd grew its position in shares of NOV by 197.1% in the first quarter. Bayforest Capital Ltd now owns 48,041 shares of the oil and gas exploration company's stock valued at $731,000 after purchasing an additional 31,873 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in NOV by 17.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,062,292 shares of the oil and gas exploration company's stock worth $16,168,000 after acquiring an additional 157,385 shares during the last quarter. Empowered Funds LLC boosted its position in NOV by 2,266.9% during the first quarter. Empowered Funds LLC now owns 509,555 shares of the oil and gas exploration company's stock worth $7,755,000 after acquiring an additional 488,027 shares during the last quarter. Finally, PharVision Advisers LLC acquired a new position in NOV during the first quarter worth about $163,000. Hedge funds and other institutional investors own 93.27% of the company's stock.
About NOV
(
Get Free Report)
NOV Inc designs, constructs, manufactures, and sells systems, components, and products for oil and gas drilling and production, and industrial and renewable energy sectors in the United States and internationally. It operates through two segments, Energy Equipment, and Energy Products and Services. The company provides solids control and waste management equipment and services, managed pressure drilling, drilling fluids, premium drillpipe, wired pipe, drilling optimization services, tubular inspection and coating services, instrumentation, downhole tools, and drill bits.
Read More

Before you consider NOV, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NOV wasn't on the list.
While NOV currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.